Companies

Boston Scientific is to acquire Rhythmia Medical, Inc. as it seeks to build its position in cardiac rhythm management. Rhythmia is a developer of mapping and navigation systems for cardiac ablation techniques and expects to have products in market next year.

Boston Scientific Corporation has announced the U.S. and European launch of its Victory™ guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature.

Boston Scientific has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus™ Valve System and the results are expected to be used to support CE mark and other international regulatory approvals.

Brilliant idea this. Use the principle behind your in car GPS to create the map of the internal organ, then fit your insertable device with sensors so you can locate it without repeat fluoroscopy. Real time navigation with reduced radiation exposure.

What could have provoked Scottish company AorTech issue proceedings against a St.Jude division? Whatever it was, S.Jude will be keen to draw a line under it, given that the agreement relates to the polymer used in its Durata lead coating.

TAVI is a great case study in technology adoption, most strikingly pointing to post-market data in the form of registries as a window on real world use of a technique which actually makes for a pretty compelling endorsement of EU regulatory rules.

Edwards’ critical care portfolio expands to Include non-Invasive platform with the acquisition of Dutch monitoring company BMEYE.

Study confirms effectiveness of directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a frontline therapy when treating PAD

With a focus on developing lesion specific solutions for peripheral artery disease, Medtronic, Inc. has announced the U.S. and international launches of the Amphirion Plus Percutaneous Transluminal Angioplasty (PTA) Catheter for the interventional treatment of atherosclerotically narrowed or occluded leg arteries below the knee.

J&J division Ethicon, Inc., has followed Covidien into the barbed suture market with the launch of its new portfolio of Stratafix™ Knotless Tissue Control Devices. The idea is that barbed sutures offer significantly more points of fixation than traditional sutures, giving surgeons more consistent control over every pass (through the tissue), and combining the strength and security of interrupted closure with the efficiency of continuous closure.

Cook Medical made the Zilver Vena™ Venous Self-Expanding Stent available to physicians across Canada at last week’s 2012 Annual Meeting of the Canadian Society for Vascular Surgery. Designed to restore blood flow in obstructed iliofemoral veins, Cook says the purpose-designed stent provides physicians with a tool designed specifically for the task.

Capsule endoscopy company Given Imaging Ltd. has acquired from The SmartPill Corporation, a U.S. based-company, the assets related to the SmartPill® GI Monitoring System for $6 million including earn-outs based on revenue between now and 2016.

Covidien has announced U.S. FDA 510(k) clearance and CE Mark approval for its next generation of Nellcor™ Bedside Respiratory Patient Monitoring system.

Medtronic’s new design multi-electrode radiofrequency renal denervation system builds on experience with the Symplicity™ Renal Denervation System.

Smith & Nephew has chosen to announce the launch of its Trigen™ Low-Profile Screw at this week’s Orthopaedic Trauma Association meeting in Minneapolis. In a press release it says Trigen is the only truly “captured” head, low-profile screw on the market.

Data published today in the Headache Society journal Cephalagia shows significant reductions in pain, headache days and migraine-related disability when Peripheral Nerve Stimulation therapy is applied.